Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, July 13, 2023
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
[ Thu, Jul 13th 2023
] - WOPRAI
Mayank Mamtani Reiterated (TGTX) at Strong Buy and Held Target at $42 on, Jul 13th, 2023
Mayank Mamtani of B. Riley Securities, Reiterated "TG Therapeutics, Inc." (TGTX) at Strong Buy and Held Target at $42 on, Jul 13th, 2023.
Mayank has made no other calls on TGTX in the last 4 months.
There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 0 agree with Mayank's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Mayank
- Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $34 on, Thursday, June 1st, 2023
- Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $38 on, Tuesday, May 2nd, 2023
- Prakhar Agrawal of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $24 on, Monday, April 17th, 2023
